Cargando…

The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study

BACKGROUND: Widespread access to the internet has boosted the emergence of online hospitals. A new outpatient service called “internet hospital plus drug delivery” (IHDD) has been developed in China, but little is known about this platform. OBJECTIVE: The aim of this study is to investigate the char...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Liang, She, Qiuru, Chen, Fengxian, Chen, Zitong, Jiang, Meifang, Huang, Huasi, Li, Yujin, Liao, Chaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419153/
https://www.ncbi.nlm.nih.gov/pubmed/32716892
http://dx.doi.org/10.2196/19678
_version_ 1783569822634737664
author Ding, Liang
She, Qiuru
Chen, Fengxian
Chen, Zitong
Jiang, Meifang
Huang, Huasi
Li, Yujin
Liao, Chaofeng
author_facet Ding, Liang
She, Qiuru
Chen, Fengxian
Chen, Zitong
Jiang, Meifang
Huang, Huasi
Li, Yujin
Liao, Chaofeng
author_sort Ding, Liang
collection PubMed
description BACKGROUND: Widespread access to the internet has boosted the emergence of online hospitals. A new outpatient service called “internet hospital plus drug delivery” (IHDD) has been developed in China, but little is known about this platform. OBJECTIVE: The aim of this study is to investigate the characteristics, acceptance, and initial impact of IHDD during the outbreak of COVID-19 in a tertiary hospital in South China METHODS: The total number of and detailed information on online prescriptions during the first 2 months after work resumption were obtained. Patients’ gender, age, residence, associated prescription department, time of prescription, payment, and drug delivery region were included in the analysis. RESULTS: A total of 1380 prescriptions were picked up or delivered between March 2 and April 20, 2020. The largest group of patients were 36-59 years old (n=680, 49.3%), followed by the 18-35 years age category (n=573, 41.5%). In total, 39.4% (n=544) of the patients chose to get their medicine by self-pickup, while 60.6% (n=836) preferred to receive their medicine via drug delivery service. The top five online prescription departments were infectious diseases (n=572, 41.4%), nephrology (n=264, 19.1%), endocrinology (n=145, 10.5%), angiocardiopathy (n=107, 7.8%), and neurology (n=42, 3%). Of the 836 delivered prescriptions, 440 (52.6%) were sent to Guangdong Province (including 363 [43.4%] to Shenzhen), and 396 (47.4%) were sent to other provinces in China. CONCLUSIONS: The IHDD platform is efficient and convenient for various types of patients during the COVID-19 crisis. Although offline visits are essential for patients with severe conditions, IHDD can help to relieve pressure on hospitals by reducing an influx of patients with mild symptoms. Further efforts need to be made to improve the quality and acceptance of IHDD, as well as to regulate and standardize the management of this novel service.
format Online
Article
Text
id pubmed-7419153
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-74191532020-08-20 The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study Ding, Liang She, Qiuru Chen, Fengxian Chen, Zitong Jiang, Meifang Huang, Huasi Li, Yujin Liao, Chaofeng J Med Internet Res Original Paper BACKGROUND: Widespread access to the internet has boosted the emergence of online hospitals. A new outpatient service called “internet hospital plus drug delivery” (IHDD) has been developed in China, but little is known about this platform. OBJECTIVE: The aim of this study is to investigate the characteristics, acceptance, and initial impact of IHDD during the outbreak of COVID-19 in a tertiary hospital in South China METHODS: The total number of and detailed information on online prescriptions during the first 2 months after work resumption were obtained. Patients’ gender, age, residence, associated prescription department, time of prescription, payment, and drug delivery region were included in the analysis. RESULTS: A total of 1380 prescriptions were picked up or delivered between March 2 and April 20, 2020. The largest group of patients were 36-59 years old (n=680, 49.3%), followed by the 18-35 years age category (n=573, 41.5%). In total, 39.4% (n=544) of the patients chose to get their medicine by self-pickup, while 60.6% (n=836) preferred to receive their medicine via drug delivery service. The top five online prescription departments were infectious diseases (n=572, 41.4%), nephrology (n=264, 19.1%), endocrinology (n=145, 10.5%), angiocardiopathy (n=107, 7.8%), and neurology (n=42, 3%). Of the 836 delivered prescriptions, 440 (52.6%) were sent to Guangdong Province (including 363 [43.4%] to Shenzhen), and 396 (47.4%) were sent to other provinces in China. CONCLUSIONS: The IHDD platform is efficient and convenient for various types of patients during the COVID-19 crisis. Although offline visits are essential for patients with severe conditions, IHDD can help to relieve pressure on hospitals by reducing an influx of patients with mild symptoms. Further efforts need to be made to improve the quality and acceptance of IHDD, as well as to regulate and standardize the management of this novel service. JMIR Publications 2020-08-06 /pmc/articles/PMC7419153/ /pubmed/32716892 http://dx.doi.org/10.2196/19678 Text en ©Liang Ding, Qiuru She, Fengxian Chen, Zitong Chen, Meifang Jiang, Huasi Huang, Yujin Li, Chaofeng Liao. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 06.08.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Ding, Liang
She, Qiuru
Chen, Fengxian
Chen, Zitong
Jiang, Meifang
Huang, Huasi
Li, Yujin
Liao, Chaofeng
The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study
title The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study
title_full The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study
title_fullStr The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study
title_full_unstemmed The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study
title_short The Internet Hospital Plus Drug Delivery Platform for Health Management During the COVID-19 Pandemic: Observational Study
title_sort internet hospital plus drug delivery platform for health management during the covid-19 pandemic: observational study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419153/
https://www.ncbi.nlm.nih.gov/pubmed/32716892
http://dx.doi.org/10.2196/19678
work_keys_str_mv AT dingliang theinternethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT sheqiuru theinternethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT chenfengxian theinternethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT chenzitong theinternethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT jiangmeifang theinternethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT huanghuasi theinternethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT liyujin theinternethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT liaochaofeng theinternethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT dingliang internethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT sheqiuru internethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT chenfengxian internethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT chenzitong internethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT jiangmeifang internethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT huanghuasi internethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT liyujin internethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy
AT liaochaofeng internethospitalplusdrugdeliveryplatformforhealthmanagementduringthecovid19pandemicobservationalstudy